Fineline Cube

Follow:
14436 Articles
CSPC Pharma's SYS6040 ADC Gains FDA Clinical Trial Approval
CompanyDrug

CSPC Pharma’s SYS6040 ADC Gains FDA Clinical Trial Approval

State Council Issues Opinions to Advance Shenzhen's Healthcare Reforms
Policy / Regulatory

State Council Issues Opinions to Advance Shenzhen’s Healthcare Reforms

Eisai's Urece Arrives in Shanghai, Poised for Chinese Market Entry
CompanyDrug

Eisai’s Urece Arrives in Shanghai, Poised for Chinese Market Entry

Sanofi to Ship Beyfortus Ahead of RSV Season, Ensuring Global Availability
CompanyDrug

Sanofi to Ship Beyfortus Ahead of RSV Season, Ensuring Global Availability

Boai NKY's LYC001 Receives Clinical Approval in China for Advanced Solid Tumors
CompanyDrug

Boai NKY’s LYC001 Receives Clinical Approval in China for Advanced Solid Tumors

Sino Biopharmaceutical's TQB2868 Approved for Phase III Trial in Metastatic Pancreatic Cancer
CompanyDrug

Sino Biopharmaceutical’s TQB2868 Approved for Phase III Trial in Metastatic Pancreatic Cancer

Ocumension Therapeutics Gains CDE Approval for Phase III Presbyopia Trial
CompanyDrug

Ocumension Therapeutics Gains CDE Approval for Phase III Presbyopia Trial

Jiangxi Rimag Plans Acquisition of Changsha Zhongya Medical for RMB 29.5 Million
CompanyDeals

Jiangxi Rimag Plans Acquisition of Changsha Zhongya Medical for RMB 29.5 Million

Biogen Launches Qalsody in China for SOD1-ALS Treatment
CompanyDrug

Biogen Launches Qalsody in China for SOD1-ALS Treatment

Boehringer Ingelheim and Echosens Expand Partnership to Tackle MASH
CompanyDeals

Boehringer Ingelheim and Echosens Expand Partnership to Tackle MASH

China Expands Medical Insurance Coverage in New State Council Guidelines
Others

China Expands Medical Insurance Coverage in New State Council Guidelines

WuXi Biologics Commences Construction on Microbial Production Base in Chengdu
Company

WuXi Biologics Commences Construction on Microbial Production Base in Chengdu